Ralf Jäger

Title: Ralf Jäger: Innovator in Women's Health

Introduction

Ralf Jäger is a notable inventor based in Trostberg, Germany. He has made significant contributions to the field of women's health through his innovative research and patenting activities. His work focuses on the therapeutic applications of creatine and its derivatives.

Latest Patents

Ralf Jäger holds a patent for the "Use of creatine and/or creatine derivatives for treating typical disorders in women." This invention addresses common issues such as PMS and dysmenorrhea. It involves the prophylactic and therapeutic use of creatine monohydrate, creatine pyruvates, creatine ascorbates, and creatine α-ketoglutarates. The preferred daily doses range from 0.1 g to 20 g. The patent also covers the use of creatine or its derivatives in mixtures with pyruvate, ascorbate, or α-ketoglutarate. This versatility in application makes these compounds particularly suitable for alleviating various symptoms associated with typical female disorders.

Career Highlights

Ralf Jäger is associated with Skw Trostberg Aktiengesellschaft, where he continues to advance his research in the field. His dedication to improving women's health through innovative solutions is evident in his work and contributions to the industry.

Collaborations

Ralf collaborates with esteemed colleagues such as Andrea Huber and Helen Louise Holland. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Ralf Jäger's innovative approach to utilizing creatine for women's health issues showcases his commitment to addressing significant health challenges. His patent and ongoing research contribute to the advancement of therapeutic options available for women.